Head and Neck Cancer Research Review, Issue 7
In this issue:
NIVOPOST-OP: nivolumab + cisplatin + radiotherapy in high-risk HNSCC
An injectable radio-sensitiser in frail older patients with HNSCC
ELAN-RT: hypofractionated split-course vs. standard radiotherapy in frail older patients with HNSCC
Camrelizumab + chemoradiotherapy in high-risk nasopharyngeal carcinoma
24-month progression-free status as a surrogate for OS in HPV+ oropharyngeal cancer
PaceAce: second-line paclitaxel + cetuximab in HNSCC
Osteoradionecrosis following proton therapy vs. IMRT in OPSCC
Outcomes following interruptions in (chemo)radiotherapy for HNSCC
De-escalated chemoradiotherapy using mid-treatment nodal response in low-risk p16+ OPSCC
De-escalated chemoradiotherapy using FDG-PET in early-stage p16+ OPSCC
Expert contributor
Dr Marcin Dzienis
Marcin Dzienis is a Medical Director at the Gold Coast University Hospital. He completed his medical degree in Poland, underwent training in medical oncology in Queensland, and undertook head-and neck and skin cancer fellowship at the Translational Research Institute and PA Hospital in Brisbane. He is involved in training, education and several professional advisory groups. […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.